Travere Therapeutics, Inc. <TVTX.O>: Stifel raises target price to $62 from $43
TVTX•Related News
Tenda enters Ibovespa first preview for year’s final four-month period
EWZ•
SolarEdge Announces Second Quarter 2026 Financial Results
SEDG•
ADP: US private-sector job growth slows to 44,000 in July
ADP•
Avnet Q4 sales beat estimates on improved demand
AVT•
Samsung, SK Hynix pledge stronger shareholder returns
SMH•